lobbying_activities: 1150596

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1150596	29be2f14-bdd6-49db-975d-37b3414664f7	Q3	CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.	8511	ONYX PHARMACEUTICALS	2011	third_quarter	MED	Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2011-10-17T11:27:41.357000-04:00